1. Home
  2. KAI vs IDYA Comparison

KAI vs IDYA Comparison

Compare KAI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kadant Inc

KAI

Kadant Inc

N/A

Current Price

$323.70

Market Cap

3.4B

Sector

Industrials

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$34.71

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KAI
IDYA
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.9B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
KAI
IDYA
Price
$323.70
$34.71
Analyst Decision
Buy
Strong Buy
Analyst Count
2
16
Target Price
$337.50
$51.21
AVG Volume (30 Days)
169.5K
795.5K
Earning Date
05-26-2026
05-19-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
61.90
EPS
8.65
N/A
Revenue
$1,052,248,000.00
$218,710,000.00
Revenue This Year
$13.28
N/A
Revenue Next Year
$4.87
$213.03
P/E Ratio
$37.92
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$244.87
$13.45
52 Week High
$374.20
$39.28

Technical Indicators

Market Signals
Indicator
KAI
IDYA
Relative Strength Index (RSI) 44.28 57.98
Support Level $317.17 $32.85
Resistance Level $346.77 $37.08
Average True Range (ATR) 17.00 1.35
MACD -1.99 0.35
Stochastic Oscillator 44.68 80.99

Price Performance

Historical Comparison
KAI
IDYA

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: